Alliance Pharma plc (AIM:APH)

Acelyrin Market Cap

Alliance Pharma is not actively traded anymore. When Alliance Pharma last traded, it had a market cap or net worth of $356.51 million.

• Market Cap: 356.51M
• Enterprise Value: 419.85M
• Revenue: 178.84M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: $64.70

Market Cap Chart

Since December 23, 2003, Alliance Pharma's market cap has increased from 5.62M to 356.51M, an increase of 6,239.51%. That is a compound annual growth rate of 21.39%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	356.51M	44.16%
Dec 31, 2024	247.31M	13.00%
Dec 29, 2023	218.86M	-23.53%
Dec 30, 2022	286.20M	-51.11%
Dec 31, 2021	585.39M	25.47%
Dec 31, 2020	466.56M	5.06%